Inhibrx Biosciences INBX
NASDAQ INBX
$98.72 +3.42 (+3.59%)
As of: Oct 21, 2026 · 1:07 PM EDT

Inhibrx Biosciences (INBX) Retained Earnings (2023 - 2026)

Updated

Inhibrx Biosciences' Retained Earnings was -$316.3 million in Q2 2026, compared with -$178.1 million a year earlier.

Analysis

Inhibrx Biosciences (INBX) Retained Earnings (2023 - 2026) Analysis & Trends

At the end of FY2025, Retained Earnings at Inhibrx Biosciences came in at -$246.19 million.

  • In earlier years, Retained Earnings was -$106.13 million in FY2024 and -$613.73 million in FY2023.
  • The Q2 2026 figure marks the lowest quarterly Retained Earnings since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,133.08 Bn 1,101.67 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 616.40 Bn 534.93 Bn 17.26 Bn 171.67 Bn
3 AbbVie 501.19 Bn 474.31 Bn 12.70 Bn -17.33 Bn
4 Merck 367.18 Bn 321.56 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn -
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 12.59 Bn
7 Amgen 235.57 Bn 190.97 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 190.62 Bn 164.82 Bn 6.22 Bn 2.20 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn 112.09 Bn
10 Inhibrx Biosciences 1.55 Bn 949.66 Mn - -316.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -316.30 Mn
Dec 31, 2025 -246.19 Mn
Sep 30, 2025 -213.40 Mn
Jun 30, 2025 -178.10 Mn
Mar 31, 2025 -149.44 Mn
Dec 31, 2024 -106.13 Mn
Sep 30, 2024 -58.30 Mn
Jun 30, 2024 -14.40 Mn
Dec 31, 2023 -613.73 Mn
API Access

Inhibrx Biosciences Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=INBX&period=max&api_key=YOUR_API_KEY